Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

ROCHE HOLDING LTD. (ROG)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Roche Holding Ltd.
Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics

Roche Holding AG operates as a research healthcare company.

It operates through the following segments: Diagnostics and Pharmaceuticals.

The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience.

The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process.

The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Number of employees : 93 734 persons.
Sales per Businesses
20162017Delta
CHF (in Million)%CHF (in Million)%
Pharmaceuticals41,04781.2%43,50481.6% +5.99%
Diagnostics11,58922.9%12,24223% +5.63%
Sales per Regions
20162017Delta
CHF (in Million)%CHF (in Million)%
United States22,95945.4%24,97546.9% +8.78%
Rest of Europe10,26720.3%10,15219% -1.12%
Rest of Asia6,47112.8%6,83812.8% +5.67%
Japan4,2438.4%4,2678% +0.57%
Germany3,0326%3,0705.8% +1.25%
Latin America2,6815.3%3,0245.7% +12.79%
Africa, Australia and Oceania1,3352.6%1,4682.8% +9.96%
Rest of North America852.001.7%898.001.7% +5.4%
Switzerland796.001.6%1,0542% +32.41%
Managers
NameAgeSinceTitle
Severin Schwan512008Chief Executive Officer & Executive Director
Christoph Franz582011Chairman
Alan Hippe, PhD672011Chief Financial & Information Technology Officer
John Irving Bell, MD662001Non-Executive Director
Andreas Oeri, MD691996Independent Non-Executive Director
Paul Bulcke642011Non-Executive Director
Peter R. Voser592011Non-Executive Director
André S. Hoffmann, MBA591996Vice Chairman
Bernard J. Poussot662015Non-Executive Director
Richard P. Lifton MD, PhD652015Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 702,562,700 693,849,723 98.8% 8,712,977 1.2% 83.5%
Share B 1 160,000,000 26,557,237 16.6% 0 0.0%
Shareholders
NameEquities%
The Vanguard Group, Inc. 18,529,379 2.64%
Norges Bank Investment Management 17,458,196 2.48%
UBS AG (Investment Management) 12,325,788 1.75%
BlackRock Fund Advisors 9,279,951 1.32%
Roche Holding AG 9,200,000 1.31%
Dodge & Cox 8,366,330 1.19%
PRIMECAP Management Co. 7,537,893 1.07%
Fidelity Management & Research Co. 7,065,860 1.01%
Credit Suisse Asset Management (Schweiz) AG 5,949,084 0.85%
Massachusetts Financial Services Co. 5,805,523 0.83%
Holdings
NameEquities%Valuation
Chugai Pharmaceutical Co Ltd (4519) 335,223,00059.9%17,583,582,756 USD
Foundation Medicine Inc (FMI) 21,019,11156.6%2,873,312,474 USD
Roche Holding Ltd. (ROG) 9,200,0001.31%2,043,466,464 USD
Senseonics Holdings Inc (SENS) 28,345,27616.2%116,499,084 USD
Curetis (CURE) 992,9046.06%5,309,435 USD
Company contact information
Roche Holding AG
Grenzacherstrasse 124
Basel, Basel-Stadt (Basle Town) 4070

Phone : +41.61.688.11.11
Fax : +41.61.691.93.91
Web : www.roche.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
ROCHE HOLDING LTD.-5.60%200 973
JOHNSON & JOHNSON-8.56%337 763
PFIZER3.59%219 534
NOVARTIS-3.93%201 464
MERCK AND COMPANY11.76%169 193
AMGEN11.60%129 635
ABBOTT LABORATORIES9.94%110 556
SANOFI0.08%104 948
GLAXOSMITHKLINE19.17%103 431
BAYER-8.75%101 760
ELI LILLY AND COMPANY6.22%97 374
NOVO NORDISK A/S-5.31%94 989
BRISTOL-MYERS SQUIBB COMPANY-7.29%92 940
ASTRAZENECA7.44%92 021
CELGENE CORPORATION-17.89%62 110
ALLERGAN PLC7.91%60 065
SHIRE11.28%52 493
JIANGSU HENGRUI MEDICINE CO LTD41.33%41 278
TAKEDA PHARMACEUTICAL CO LTD-27.83%33 163
ASTELLAS PHARMA INC22.86%31 377
EISAI CO., LTD67.31%28 678
Connections : Roche Holding Ltd.
Tate Gallery Foundation, Inc.
International Federation of Pharmaceutical Manufacturers
Inovalon, Inc.
International Committee of the Red Cross
Fondation Hoffmann
European Round Table of Industrialists
Fondation Dr Henri Dubois-Ferrière Dinu Lipatti
Credit Suisse AG
New York Genome Center
Zurich Insurance Co. Ltd.
Fondation Internationale du Banc d'Arguin
Stadler Rail AG
WWF International
Weidenfeld Hoffmann Trust
Zurich Insurance Group Ltd.
Fort Dodge Animal Health, Inc.
Lucerne Festival
Swiss-American Chamber of Commerce
Voith GmbH
Fondation pour l’art musical, lyrique et chorégraphique
Immunocore Ltd.
Givaudan Foundation
The Oxford Health Alliance
GMEC Management Co. Ltd.
Fondation Tour du Valat
Office for Strategic Co-ordination of Health Research
Fondation Auxiliaire du Conservatoire botanique de la Ville de
Oxagen Ltd.
Fondation Jan Michalski Pour L'écriture Et La Littérature
Oxford University Hospitals NHS Trust
Eisenhower Fellowships, Inc.
The Gray Laboratory Cancer Research Trust
The Rockefeller University
Rhodes Trust
International Business Leaders Advisory Council
The Ewelme Almshouse Charity
Peter G. Peterson Institute for International Economics
Genomics England Ltd.
Fondation MAVA
Oxford Centre for Diabetes Endocrinology & Metabolism
Fondation Pro Valat
The Jenner Institute Laboratories
Institute For Strategic Dialogue
Credit Suisse (Schweiz) AG
Cereal Partners Worldwide SA
Amazentis SA
2030 Water Resources Group
Glyndebourne Productions Ltd.
Fondation les Corbillettes
Nestlé Health Science SA
Peace Parks Foundation
Nestlé Skin Health SA
Paul Sacher Stiftung
L'Oréal USA, Inc.
Fondation Prince Albert II of Monaco
Forum Mondial de L'Economie
Systemiq Ltd.
IMD Scholarship Foundation
University of Oxford
Max Planck Florida Institute for Neuroscience
St. Gallen Foundation for International Studies
Cargill, Inc.
Roche Holdings, Inc.
ESCP Europe Campus Paris
Temasek Holdings (Pte) Ltd.
The Rockefeller Archive Center
Catalyst, Inc.
Yale School of Medicine
© 2018 People , Fundamentals and Ownership